Wednesday 12th December 2018


Registration and Coffee

Introduction to IPAC-RS

09.00 - 09.10

Membership, structure, strategic priorities, overview of workstreams, accomplishments and impact

Jeremy Clarke, GSK

Delivery Systems Workstream – activity update

09.10 - 09.35

Medical Device Regulations

Tim Chesworth, AstraZeneca

09.35 - 10.00

Human Factors

Roisin Wallace, Mylan

10.00 - 10.25

Instructions for Use

Julian Dixon, Team Consulting

10.50 - 11.25

Refreshment Break

General Workstream -activity update

10.50 -11.25

A review of FDA draft guidance on Metered Dose Inhaler and Dry Powder Inhaler Drug Products – Quality Considerations

Gustavo Marco, GSK

CMC and Product Development Test Workstream –¬†activity update

11.25 - 12.00

Cascade Impaction testing and data analysis, regulatory and pharmaceutical developments

Adrian Goodey, Merck

Jolyon Mitchell, OIP Consultant